Topics

Transkaryotic Therapies Incorporated RKT Company Profile

03:24 EST 22nd November 2019 | BioPortfolio

Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein products for rare and common diseases. Through its three development platforms Niche Protein® products, Gene-Activated® proteins, and Gene Therapy, TKT currently has products in clinical development for the treatment of Fabry disease, anemia, Hunter syndrome, hemophilia A. The breadth of TKT's pipeline is a result of the company's strong scientific base, which integrates cellular and molecular biology and protein chemistry to develop biologics.

Location

195 Albany Street
Cambridge
MA
02139
United States of America

Contact

Phone: 617 349 0200
Fax: 617 491 7903
Email: info@tktx.com


News Articles [300 Associated News Articles listed on BioPortfolio]

TScan Closes on Series B to Develop Next-Generation Immuno-Oncology Therapies

The company’s focus is on improving immuno-oncology therapies, making them more effective for the patients for whom these new therapies don’t work and by decreasing serious side effects.

Interview: As Gene and Cell Therapies Grow, the Reimbursement Model Needs to Change

Although the advent of cell and gene therapies is revolutionizing medicine, it is arguable that the therapies that have been approved to date in this area aren’t living up to expectations.

Interview: As Gene and Cell Therapies Grow, Reimbursement Model Needs to Change

Although the advent of cell and gene therapies is revolutionizing medicine, it is arguable that the therapies that have been approved to date in this area aren’t living up to expectations.

Advanced Therapies Feature in New IMI Call for Proposals

Advanced therapies are a major part of new Innovative Medicines Initiative (IMI) Calls for proposals. The two advanced therapies topics aim to accelerate research into advanced therapies for rare dise...

Complementary and alternative therapies to treat colic

(University of Bristol) A review of the evidence on the use of complementary and alternative (CAM) therapies to treat babies with colic has shown some that some treatments -- including probiotics, fen...

ACPs to lead gene therapies in haemophilia market growth

New therapies to hit existing players

NIH, Gates pledge $200m for HIV and sickle cell gene therapies

Aim to bring therapies to patients in lower-income countries

The Next Frontier of CAR-T Therapies: Off-the-Shelf Therapies

While this type of personalized therapy is revolutionizing cancer treatment and healthcare, it has some formidable limitations.

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Urea [exact-rx, inc.]

Urea Nail Gel 45% (in a vehicle containing camphor, menthol and eucalyptus oil) Rx Only

Urea [exact-rx, inc.]

Urea Cream 45%

Sodium sulfacetamide, sulfur [exact-rx, inc.]

Sodium Sulfacetamide 10% and Sulfur 5% CleanserRx only

Sodium sulfacetamide [exact-rx, inc.]

SODIUM SULFACETAMIDE 10% WASH (sodium sulfacetamide 10%) Rx Only

Phendimetrazine tartrate [calvin, scott and company, incorporated]

Phendimetrazine Tartrate Tablets USP, 35 mg CIIIRx only

PubMed Articles [567 Associated PubMed Articles listed on BioPortfolio]

Laughter-inducing therapies: Systematic review and meta-analysis.

Laughter-inducing therapies are being applied more regularly in the last decade, and the number of scientific reports of their beneficial effects is growing. Laughter-inducing therapies could be cost-...

Why do we give "orphan" approval to biologic therapies but not to extracorporeal blood purification therapies for hyperinflammatory syndromes?

Non-antibiotic therapy for infection: A review.

infection (CDI) is a common infectious disease that is mainly caused by antibiotics. Antibiotic therapy is still the dominant treatment for CDI, although it is accompanied by side effects. Probiotics,...

A Hospital-based Study of the Prevalence and Usage of Complementary and Alternative Medicine Among Saudi Psychiatric Patients.

Introduction Complementary and alternative medicine (CAM) therapies, used singularly or in combination with more conventional therapies, are routinely used by citizens of the Kingdom of Saudi Arabia (...

Synthesizing the Strength of the Evidence of Complementary and Integrative Health Therapies for Pain.

Pain and opioid use are highly prevalent, leading for calls to include nonpharmacological options in pain management, including complementary and integrative health (CIH) therapies. More than 2,000 ra...

Clinical Trials [1925 Associated Clinical Trials listed on BioPortfolio]

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

The purpose of this study is to observe and describe treatment patterns, like Overactive Bladder (OAB) treatment discontinuation, switching to other therapies and persistence of OAB therap...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

This is a 2‑arm, randomized, placebo-controlled, double‑blind, international, multicenter study comparing the efficacy of DCC-2618 to placebo in patients who have received treatment wi...

Intensive Therapies in Children With Hemiplegia

This is a comparative study where two protocols of intensive therapies will be applied to study the improvements in the functional performance of the affected upper limb of children with h...

Companies [991 Associated Companies listed on BioPortfolio]

Transkaryotic Therapies Incorporated RKT

Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein pro...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

Garmin Ltd.

Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin is a registered trademark of Gar...

OS Therapies Inc.

OS Therapies Inc. (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet...

More Information about "Transkaryotic Therapies Incorporated RKT" on BioPortfolio

We have published hundreds of Transkaryotic Therapies Incorporated RKT news stories on BioPortfolio along with dozens of Transkaryotic Therapies Incorporated RKT Clinical Trials and PubMed Articles about Transkaryotic Therapies Incorporated RKT for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Transkaryotic Therapies Incorporated RKT Companies in our database. You can also find out about relevant Transkaryotic Therapies Incorporated RKT Drugs and Medications on this site too.

Quick Search

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record